Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

XLTEK completes US$22.5 million IPO

Reading Time 1 minute read Subscribe



GMP Securities

On April 25, 2006, Excel-Tech Ltd. ("XLTEK") completed its initial public offering of 4,500,000 common shares at a price of $5 per share for aggregate gross proceeds of $22.5 million. GMP Securities L.P. acted as lead underwriter of a syndicate that also included Canaccord Capital Corporation, Raymond James Ltd. and Versant Partners Inc. XLTEK is a medical technology company that designs, develops and sells proprietary medical devices used to monitor the central and peripheral nervous systems and used in the diagnosis of related disorders. The underwriters of the offering were represented by Fasken Martineau with a team that included Rubin Rapuch, Georges Dubé and Jamie Pennell.



    Receive email updates from our team